INS and metabolic syndrome: There is a growing interest among scientists worldwide in investigating the role of NLRP3 inflammasome activation in the pathogenesis of metabolic disorders, and many reports, including our recent review [21], have helped in understanding NLRP3-mediated adipose tissue inflammation and impairment of insulin signaling pathway leading to IR and MetS.